Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?
Publication
, Other
Pollack, CV; Levy, JH; Eikelboom, J; Weitz, JI; Sellke, FW; Huisman, MV; Steiner, T; Kamphuisen, P; Bernstein, RA
Published in: Am J Emerg Med
November 2014
Duke Scholars
Published In
Am J Emerg Med
DOI
EISSN
1532-8171
Publication Date
November 2014
Volume
32
Issue
11
Start / End Page
1433 / 1434
Location
United States
Related Subject Headings
- beta-Alanine
- Tissue Plasminogen Activator
- Stroke
- Male
- Humans
- Fibrinolytic Agents
- Emergency & Critical Care Medicine
- Dabigatran
- Benzimidazoles
- Atrial Fibrillation
Citation
APA
Chicago
ICMJE
MLA
NLM
Pollack, C. V., Levy, J. H., Eikelboom, J., Weitz, J. I., Sellke, F. W., Huisman, M. V., … Bernstein, R. A. (2014). Dabigatran-related coagulopathy: when can we assume the effect has "worn off"? Am J Emerg Med. United States. https://doi.org/10.1016/j.ajem.2014.08.072
Pollack, Charles V., Jerrold H. Levy, John Eikelboom, Jeffrey I. Weitz, Frank W. Sellke, Menno V. Huisman, Thorsten Steiner, Pieter Kamphuisen, and Richard A. Bernstein. “Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?” Am J Emerg Med, November 2014. https://doi.org/10.1016/j.ajem.2014.08.072.
Pollack CV, Levy JH, Eikelboom J, Weitz JI, Sellke FW, Huisman MV, et al. Dabigatran-related coagulopathy: when can we assume the effect has "worn off"? Vol. 32, Am J Emerg Med. 2014. p. 1433–4.
Pollack, Charles V., et al. “Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?” Am J Emerg Med, vol. 32, no. 11, Nov. 2014, pp. 1433–34. Pubmed, doi:10.1016/j.ajem.2014.08.072.
Pollack CV, Levy JH, Eikelboom J, Weitz JI, Sellke FW, Huisman MV, Steiner T, Kamphuisen P, Bernstein RA. Dabigatran-related coagulopathy: when can we assume the effect has "worn off"? Am J Emerg Med. 2014. p. 1433–1434.
Published In
Am J Emerg Med
DOI
EISSN
1532-8171
Publication Date
November 2014
Volume
32
Issue
11
Start / End Page
1433 / 1434
Location
United States
Related Subject Headings
- beta-Alanine
- Tissue Plasminogen Activator
- Stroke
- Male
- Humans
- Fibrinolytic Agents
- Emergency & Critical Care Medicine
- Dabigatran
- Benzimidazoles
- Atrial Fibrillation